Instituts de recherche en santé du Canada
570 556 captures · dernière capture : 3 mai 2026
Page d’accueil :https://cihr-irsc.gc.ca/f/193.html
Le français est une traduction alpha automatisée. Pour le texte officiel, consultez la version anglaise.
Explorateur d’archives
Parcourir et rechercher des captures
Note importante
Parcourez et recherchez des captures historiques. Ceci est une archive — pas des directives actuelles ni un avis médical. Le contenu archivé peut être incomplet, périmé ou remplacé. Pour des recommandations à jour, consultez toujours le site officiel de la source.
Pour plus de contexte sur la couverture et les méthodes de capture, voir Méthodes et couverture.
Parcourir les sites archivés
Santé Canada
386 223 captures · dernière capture : 14 avr. 2026
Page d’accueil :https://www.canada.ca/fr/sante-canada.html
Agence de la santé publique du Canada
243 880 captures · dernière capture : 28 avr. 2026
Page d’accueil :https://www.canada.ca/fr/sante-publique.html
Canada’s regulatory approach to drugs for rare diseases: orphan drugs From Health Canada Canada's regulatory approach Clinical trials: apply and register Find a clinical trial Find drug reviews and decisions About orphan drugs and rare diseases Our role in bringing drugs to…
Consultations on improving the regulatory review of drugs and devices Current Status: Open We are improving the regulatory review process of drugs and medical devices in Canada. We are committed to openness and transparency and we want you to have your say throughout the process.…
Mandatory reporting of serious adverse drug reactions and medical device incidents by hospitals: Overview New products under serious adverse reaction hospital reporting requirements: Notice [2023-02-15] Related acts and regulations Food and Drugs Act Food and Drug Regulations…
How else we use or share your personal information The Canada Vigilance Program may share your personal information with other programs within Health Canada that support mandatory reporting by hospitals.
Suspect a serious adverse drug reaction or medical device incident Download the alternative format (PDF format, 674 KB, 1 page) Organization: Health Canada Type: Poster Published: 2019-06-26 There are new reporting requirements for hospitals Every report counts Together they tell…
Mandatory reporting by hospitals of serious adverse drug reactions related to biocides: Notice Learn how the new Biocides Regulations will change mandatory reporting obligations for hospitals. On this page New regulations for biocides About mandatory reporting and biocides…
New products for serious adverse drug reaction hospital reporting: Notice February 15, 2023 Our file number: 23-101396-13 New products have been added to those that fall under the serious adverse drug reaction (ADR) reporting requirements for hospitals. The additions are a result…
Health products post-market surveillance cycle Download in PDF format (542 KB, 2 pages) Organization: Health Canada Date published: August 2024 Recognize All health products have risks and benefits associated with their use. Drug and medical device safety knowledge and issues…
Applications for Medical Device Investigational Testing Authorizations Guidance Document - Summary From Health Canada Overview This guidance document provides information on applications for Investigational Testing Authorization (ITA). This includes ITA review process…
Label Safety Assessment Update Product Monograph Brand Safety Updates [2018-03-23] Page details 2018-03-23
Page 2333 sur 3977Affichage de 23321 à 23330 sur 39762
Version préliminaire : la couverture et les fonctionnalités sont encore en expansion.
